Clinical significance of CHAC1 in breast and ovarian cancer

被引:0
|
作者
Goebel, Georg [1 ]
Berger, Regina [2 ]
Strasak, Alexander [1 ]
Egle, Daniel [2 ]
Mueller-Holzner, Elisabeth [2 ]
Schmidt, Stefan [3 ]
Rainer, Johannes [4 ]
Presul, Elisabeth [2 ]
Parson, Walter [5 ]
Lang, Stefan [6 ]
Jones, Allison [7 ]
Widschwendter, Martin [7 ]
Fiegl, Heidi [2 ]
机构
[1] Innsbruck Med Univ, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Gynecol & Obstet, A-6020 Innsbruck, Austria
[3] Innsbruck Med Univ, Dept Internal Med 5, A-6020 Innsbruck, Austria
[4] Innsbruck Med Univ, Div Mol Pathophysiol, Bioctr Innsbruck, A-6020 Innsbruck, Austria
[5] Leopold Franzens Univ, Inst Legal Med, Innsbruck, Austria
[6] Leopold Franzens Univ, Dept Stat, Fac Econ & Stat, Innsbruck, Austria
[7] UCL, Dept Gynecol Oncol, UCL EGA Inst Womens Hlth, London W1T 7DN, England
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
234
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [1] Prognostic significance of CHAC1 expression in breast cancer
    Mehta, Vikrant
    Meena, Jaipal
    Kasana, Harit
    Munshi, Anjana
    Chander, Harish
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (09) : 8517 - 8526
  • [2] Prognostic significance of CHAC1 expression in breast cancer
    Vikrant Mehta
    Jaipal Meena
    Harit Kasana
    Anjana Munshi
    Harish Chander
    Molecular Biology Reports, 2022, 49 : 8517 - 8526
  • [3] CHAC1 EXPRESSION IN BREAST CANCER
    Fiegl, H.
    Wolf, B.
    Goebel, G.
    Berger, R.
    Mueller-Holzner, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [4] Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
    G Goebel
    R Berger
    A M Strasak
    D Egle
    E Müller-Holzner
    S Schmidt
    J Rainer
    E Presul
    W Parson
    S Lang
    A Jones
    M Widschwendter
    H Fiegl
    British Journal of Cancer, 2012, 106 : 189 - 198
  • [5] Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients
    Goebel, G.
    Berger, R.
    Strasak, A. M.
    Egle, D.
    Mueller-Holzner, E.
    Schmidt, S.
    Rainer, J.
    Presul, E.
    Parson, W.
    Lang, S.
    Jones, A.
    Widschwendter, M.
    Fiegl, H.
    BRITISH JOURNAL OF CANCER, 2012, 106 (01) : 189 - 198
  • [6] Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1
    Jahn, Beate
    Arvandi, Marjan
    Rochau, Ursula
    Fiegl, Heidi
    Goebel, Georg
    Marth, Christian
    Siebert, Uwe
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (07) : 563 - 574
  • [7] CHAC1 catabolizes glutathione and mediates heme toxicity
    Crawford, R. R.
    Higdon, A. N.
    Mungrue, I. N.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [8] ChaC1 upregulation reflects poor prognosis in a variety of cancers: analysis of the major missense SNPs of ChaC1 as an aid to refining prognosis
    Parande, Devraj
    Suyal, Shradha
    Bachhawat, Anand K.
    GENE, 2024, 913
  • [9] High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues
    Vikrant Mehta
    Prabhat Suman
    Harish Chander
    Clinical and Translational Oncology, 2022, 24 : 2351 - 2365
  • [10] High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues
    Mehta, Vikrant
    Suman, Prabhat
    Chander, Harish
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (12): : 2351 - 2365